Client, Year

Elixirgen Therapeutics, 
2020

Services

Logo
UX/UI
Website
Illustration

Elixirgen Therapeutics

A brand to keep pace with scientific breakthroughs

Elixirgen develops and delivers therapies for genetic diseases and vaccines. While Ashton was building a brand identity for the biotech firm, their sub-company, Elixirgen Therapeutics, created a breakthrough vaccine for COVID-19.  We collaborated to relaunch their identity and website in just one month to coincide with the company’s press releases.

ET_logo
ET_Logo_explainb
ET_Logo4d

The identity was inspired by Elixirgen’s mission to cure humanity’s ailments using stem cell biology. San serif and monospace fonts exude a scientific, modern feel. The icon encapsulates the company’s two-track pursuit of immunity + immortality and rejuvenation + regeneration. 

ET_Logo3
ET_Colors2

To distinguish Elixirgen Therapeutics from its parent company, we reconfigured the original logo and tweaked its color palette. Custom diagrams and graphics helped explain how the vaccine works.

ET_Diagrams2

We then designed and built a website to house the company’s COVID-19 research and breakthroughs.  The urgent nature of the subject matter put the project on an expedited timeline, with all hands on deck.

ET_Web_homepage3
ET_Tablet-Phone3

Aesthetically, the website needed to strike a careful balance between scientific and people-centric to differentiate Elixirgen Therapeutics from other cell therapy labs.

After a month of identity design and iteration, web design, and web development, the website successfully launched on June 3rd, 2020 to coincide with Elixirgen Therapeutics’ COVID-19 vaccine press release.

ABET_Thumbnail_1920x1200
ELSCO_1_header

Stay in Touch

ashton_logo-white

PO Box 50337, Balt., MD 21211

©2024 Ashton Design

PO Box 50337, Balt., MD 21211

Stay in Touch